F

Farmax

FARMAXIND

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has reduced debt.
  • Stock is trading at 0.12 times its book value

Weaknesses

4
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -27.3% over past five years.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 89.4 to 144 days.

Growth Rate

Revenue Growth
-98% lower than 3Y
Net Income Growth
72% higher than 3Y

Quarterly Results

Particulars Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018
Sales
7.98
4.82
5.8
4.19
2.85
2.32
1.86
0.11
0.1
0.09
0
0
0
Expenses
9.32
7
7.01
8.83
3.14
4.81
2.19
0.6
0.01
0.11
0
0.03
0.03
Operating Profit
-1.34
-2.18
-1.21
-4.64
-0.29
-2.49
-0.33
-0.49
0.09
-0.02
0
-0.03
-0.03
OPM %
-16.79%
-45.23%
-20.86%
-110.74%
-10.18%
-107.33%
-17.74%
-445.45%
90%
-22.22%
Other Income
1.53
0.08
0.06
0
0.09
0.04
0
0
0
0
0
0
0
Interest
-5.2
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.71
0.41
0.41
0.42
0.36
0.32
0.33
0.32
0.34
0.32
0.32
0.27
0.27
PBT
4.68
-2.51
-1.56
-5.06
-0.56
-2.77
-0.66
-0.81
-0.25
-0.34
-0.32
-0.3
-0.3
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
4.68
-2.51
-1.57
-5.06
-0.56
-2.77
-0.66
-0.81
-0.25
-0.35
-0.32
-0.3
-0.3
EPS in Rs
0.09
-0.05
-0.03
-0.09
-0.01
-0.05
-0.01
-0.02
0
-0.01
-0.01
-0.01
-0.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Aug 2008 17mMar 2009 7mMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016TTM
Sales
5.02
6.06
16.82
19.73
63.41
77.25
91.43
47.48
17.32
20.98
15.69
0.09
Expenses
4.28
5.27
14.61
17.68
54.96
69.82
86.04
64.58
18.34
22.58
24.15
0.17
Operating Profit
0.74
0.79
2.21
2.05
8.45
7.43
5.39
-17.1
-1.02
-1.6
-8.46
-0.08
OPM %
14.74%
13.04%
13.14%
10.39%
13.33%
9.62%
5.9%
-36.02%
-5.89%
-7.63%
-53.92%
-88.89%
Other Income
0
0
0
0
-1.13
1.26
1.75
-102
0.38
1.78
0.29
0
Interest
0.01
0.01
0.34
0.6
2.43
3.73
4.82
4.73
6.18
0.06
0.01
0
Depreciation
0.36
0.36
1.37
0.78
1.67
2.45
4.76
2.54
2.02
2.22
1.6
1.18
PBT
0.37
0.42
0.5
0.67
3.22
2.51
-2.44
-127
-8.84
-2.1
-9.78
-1.26
Tax %
37.84%
38.1%
36%
37.31%
24.22%
14.34%
-24.59%
0.57%
0%
0%
0%
Net Profit
0.23
0.26
0.32
0.42
2.44
2.15
-1.84
-127
-8.84
-2.1
-9.78
-1.27
EPS in Rs
0.03
0.04
0.08
-0.07
-3.12
-0.22
-0.04
-0.18
-0.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Aug 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Equity Capital
3.22
3.22
11
11
12.6
25.83
25.83
40.83
40.83
53.42
53.42
Reserves
0.55
0.81
13.58
14
18.84
316
75.03
-45.69
-54.53
-52.61
-62.39
Borrowings
0
0
9.01
11.18
16.13
37.2
30.07
35.38
41.49
41.02
41
Other Liabilities
0.57
0.59
4.29
2.49
2.34
7.99
3.18
1.97
3.15
2.92
1.83
Total Liabilities
4.34
4.62
37.88
38.67
49.91
387
134
32.49
30.94
44.75
33.86
Fixed Assets
1.22
0.86
23.2
23.17
28.34
30.9
26.29
23.98
22.05
20.07
18.37
CWIP
0
0
0
2.43
0
0
0
0
0
0
0
Investments
1.11
1.15
1.15
1.15
0
253
0.34
0
0
0
0
Other Assets
2.01
2.61
13.53
11.92
21.57
103
107
8.51
8.89
24.68
15.49
Total Assets
4.34
4.62
37.88
38.67
49.91
387
134
32.49
30.94
44.75
33.86
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Aug 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Operating
-3.95
-2.85
-19.95
-0.46
-17.43
-0.41
Investing
-326
1.26
-3.78
0.42
1.56
1.22
Financing
330
1.58
23.79
-0.03
16.09
-4.06
Net Cash Flow
0.46
-0.01
0.06
-0.07
0.22
-3.25
Free Cash Flow
-8.96
-2.92
-20.1
-0.46
-17.62
0.51
CFO/OP
-57
-53
117
45
1,089
5
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Aug 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Debtor Days
66.89
69.27
173
83.25
58.08
73.24
67.59
1.23
3.58
121
144
Inventory Days
78.54
35.93
69.85
69.63
17.18
76.65
160
32.33
Days Payable
36.05
5.33
10.66
3.94
2.19
36.04
45.1
23
Cash Conversion Cycle
66.89
69.27
173
126
88.68
132
133
16.23
44.19
236
153
Working Capital Days
95.98
110
194
167
108
123
131
8.23
8.43
281
188
ROCE %
11.03%
4.47%
16.24%
2.92%
0.93%
-23.87%
-9.12%
-5.86%
-26.46%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Farmax insights

56 extracted metrics + investor summaries across FY06–FY16.

Log in — free

Shareholding Pattern

Public68.19%DIIs0.84%Promot.30.98%As ofDec 2017

Documents

Frequently Asked Questions about Farmax

What does Farmax India Ltd do?
Farmax India Ltd, incorporated in India, listed on the Bombay Stock Exchange Limited, the company is engaged in Atta,pasta,vermicelli, maida,rawa
Which sector does Farmax India Ltd belong to?
Farmax India Ltd is classified under the Fast Moving Consumer Goods sector, in the Household Products industry.

Company Information

Farmax India Ltd, incorporated in India, listed on the Bombay Stock Exchange Limited, the company is engaged in Atta,pasta,vermicelli, maida,rawa

Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FARMAXIND.md for Farmax India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More